Prosecution Insights
Last updated: August 07, 2026
Application No. 18/027,697

CARDIAC ABLATION SYSTEM AND METHOD

Non-Final OA §103
Filed
Mar 22, 2023
Priority
Sep 22, 2020 — CN 202011005029.0 +2 more
Examiner
OUYANG, BO
Art Unit
3794
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Suzhou Innoventures Co. Ltd.
OA Round
3 (Non-Final)
61%
Grant Probability
Moderate
3-4
OA Rounds
7m
Est. Remaining
70%
With Interview

Examiner Intelligence

Grants 61% of resolved cases
61%
Career Allowance Rate
243 granted / 400 resolved
-9.2% vs TC avg
Moderate +9% lift
Without
With
+8.9%
Interview Lift
resolved cases with interview
Typical timeline
4y 0m
Avg Prosecution
42 currently pending
Career history
451
Total Applications
across all art units

Statute-Specific Performance

§101
1.2%
-38.8% vs TC avg
§103
58.5%
+18.5% vs TC avg
§102
21.1%
-18.9% vs TC avg
§112
16.4%
-23.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 400 resolved cases

Office Action

§103
DETAILED ACTION Applicant's amendments and remarks, filed 7/17/26, are fully acknowledged by the Examiner. Currently, claims 1, 12, 14, and 15 are pending with claims 1, 12, 14, and 15 amended. Applicant's amendment to claim 1 has overcome the previously filed 35 USC 112(b) rejection. The following is a complete response to the 7/17/26 communication. Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 7/17/26 has been entered. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1, 12, 14 is/are rejected under 35 U.S.C. 103 as being unpatentable over Sara (US 2017/0135740) in view of Kunis (US 2007/0083194). Regarding claim 1, Sara teaches a cardiac ablation system for treating cardiac tissue comprising a catheter (catheter 12) and a head, the head being an ablation end of the cardiac ablation system for cardiac tissue (head 18), and the catheter being a flexible tubular connector used by the cardiac ablation system to couple to the head (28 to connect to 18 as in par. [0026]), wherein: the head comprises a plurality of elongate ablation elements (18 as multiple lobes 20); each ablation element is provided with a contact surface for contacting cardiac tissue and a flexible support body for supporting the contact surface (54), wherein an energy acting part is arranged on the contact surface (54 as the energy acting part); at least some of the ablation elements are arranged for resilient engagement with the tissue (54 of lobes 20 to contact tissue as in par. [0029]); the ablation elements are individually movable (20 inflates and deflates), the resilient engagement comprising resilient displacement (20 inflates and deflates to place the lobe accordingly and par. [0040]), the ablation element has two operating states of contraction and extension at the head position of the cardiac ablation system (lobes may be inflated and deflated); in the contraction state, a plurality of individual ablation elements aggregate with each other and present a minimum volume (lobes deflated as in Fig. 8); in the extension state, one or more mutually individual ablation elements open and adapt to various shape changes at the point where the cardiac tissue is contacted through the contact surfaces on each ablation element (Fig. 7, lobes inflated to contact cardiac wall as in par. [0037]), the head includes at least one inflatable balloon (18), the balloon coupled to the head and the ablation elements are arranged around a peripheral edge of the balloon (20 around 18), wherein on inflation, the balloon is arranged to bias the elongate ablation elements to be displaced so as to project radially outwards from a center of the head (as in at least Figs. 4-5). Sara is not explicit regarding the balloon being a separate element from the ablation elements and being central to the ablation elements relative to a center of the head, the balloon individually movable relative to the ablation elements. However, Kunis teaches ablation elements made of metal as a separate element from a balloon, the balloon being centered relative to the ablation elements and moving relative to the ablation elements. (par. [0133] and electrodes 172 as in Fig. 10 on a central balloon). It would have been obvious to one of ordinary skill in the art to modify Sara with the electrodes as the ablation element as in Kunis, such that the device does RF . Sara suggests other energy modalities may be used such as RF energy, using electrodes (par. [0034]). Using the electrodes of Kunis as the energy modality would allow for such electrosurgical treatment of tissue on a balloon interface that can be adjusted. Regarding claim 12, Sara teaches wherein the head includes a selectively movable housing, the housing arranged to selectively move the ablation elements from a distal or proximal position to a position opposite the distal or proximal position, such that the ablation elements are arranged to resiliently project radially from the center of the head (lobes 20 project from the head as in at least Fig. 5). Regarding claim 14, Sara teaches wherein there are a plurality of balloons coupled to the head, the balloons selectively inflatable, the balloons arranged to be of a different inflation, the elements arranged to be displaced differently (Fig. 8). Claim(s) 15 is/are rejected under 35 U.S.C. 103 as being unpatentable over Sara in view of Kunis, in further view of Tilson (US 2015/0141917). Regarding claim 15, Sara is silent wherein the balloons are annular. However, Tilson teaches balloons for a similar ablation use as annular (par. [0214]). It would have been obvious to one of ordinary skill in the art to modify Sara with the annular balloons of Tilson, allowing for blood flow through the balloons. Response to Arguments Applicant's arguments filed 7/17/26 have been fully considered but they are not persuasive. Kunis teaches ablation elements separate from the balloon for a different treatment modality, as desired by Sara. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to BO OUYANG whose telephone number is (571)272-8831. The examiner can normally be reached M-F 8-5 EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joanne Rodden can be reached at 303-297-4276. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /BO OUYANG/Examiner, Art Unit 3794 /MICHAEL F PEFFLEY/Primary Examiner, Art Unit 3794
Read full office action

Prosecution Timeline

Mar 22, 2023
Application Filed
Jul 11, 2025
Non-Final Rejection mailed — §103
Nov 07, 2025
Response Filed
Mar 17, 2026
Final Rejection mailed — §103
Jul 17, 2026
Request for Continued Examination
Jul 21, 2026
Response after Non-Final Action
Jul 30, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12697167
APPARATUS AND METHODS FOR MINIMALLY INVASIVE DISSECTION AND MODIFICATION OF TISSUES
5y 0m to grant Granted Aug 04, 2026
Patent 12667410
ELECTROSURGICAL DEVICE
4y 4m to grant Granted Jun 30, 2026
Patent 12653607
INTRAVASCULAR CATHETER TIP ELECTRODE ASSEMBLIES
5y 5m to grant Granted Jun 16, 2026
Patent 12653604
DEVICE AND METHOD FOR FRACTIONAL RF TREATMENT OF THE SKIN
4y 6m to grant Granted Jun 16, 2026
Patent 12588940
TESTING DEVICE FOR AN ELECTROSURGICAL GENERATOR
5y 6m to grant Granted Mar 31, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
61%
Grant Probability
70%
With Interview (+8.9%)
4y 0m (~7m remaining)
Median Time to Grant
High
PTA Risk
Based on 400 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month